Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
11.75 (1y: +73%)
Market Cap 800.12 M P/E(ttm) 160.80
Enterprise Value 641.89 M P/B 5.05
NBIX- NAS (USA)
Neurocrine Biosciences, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$11.75
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M800Revenue $M42.6Net Margin (%)9.5Z-Score7.8
Enterprise Value $M630EPS $-0.1Operating Margin %2.7F-Score2
P/E(ttm))161Cash Flow Per Share $0.7Pre-tax Margin (%)9.5Higher ROA y-yN
Price/Book5.110-y EBITDA Growth Rate %0Quick Ratio2.8Cash flow > EarningsN
Price/Sales19.05-y EBITDA Growth Rate %0Current Ratio7.7Lower Leverage y-yY
Price/Cash Flow10.0y-y EBITDA Growth Rate %-127.8ROA % (ttm)2.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)3.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M66.5ROI % (ttm)-2.5Gross Margin Increase y-yN

Gurus Latest Trades with NBIX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 80. The trades of Premium Gurus are not included unless they are in your Personalized List

Total Records: 18
TickerdownGuruDate Action
 Impact Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
NBIXJoel Greenblatt 2012-12-31 Sold Out -0.13%$6.88 - $8.66
($7.6)		 $ 11.7555%Sold Out0
NBIXJoel Greenblatt 2012-06-30 Add0.03%$6.31 - $8.06
($7.18)		 $ 11.7564%Add 23.8%259,903
NBIXGeorge Soros 2012-06-30 Sold Out -0.02%$6.31 - $8.06
($7.18)		 $ 11.7564%Sold Out0
NBIXJoel Greenblatt 2012-03-31 Buy 0.15%$7.33 - $9.79
($7.95)		 $ 11.7548%New holding, 209930 sh.209,930
NBIXGeorge Soros 2012-03-31 Buy 0.02%$7.33 - $9.79
($7.95)		 $ 11.7548%New holding, 150000 sh.150,000
NBIXGeorge Soros 2011-12-31 Sold Out -0.0018%$5.5 - $8.58
($6.76)		 $ 11.7574%Sold Out0
NBIXGeorge Soros 2011-09-30 Reduce$5.59 - $8.44
($6.71)		 $ 11.7575%Reduce -23.93%17,800
NBIXGeorge Soros 2011-06-30 Add$6.82 - $8.3
($7.54)		 $ 11.7556%Add 90.24%23,400
NBIXGeorge Soros 2011-03-31 Add$6.47 - $7.84
($7.2)		 $ 11.7563%Add 23%12,300
NBIXGeorge Soros 2010-12-31 Buy $5.99 - $8.53
($7.63)		 $ 11.7554%New holding, 10000 sh.10,000
NBIXGeorge Soros 2008-06-30 Sold Out -0.01%$4.28 - $5.86
($5)		 $ 11.75135%Sold Out0
NBIXGeorge Soros 2008-03-31 Buy 0.01%$4.51 - $5.58
($5.1)		 $ 11.75130%New holding, 21038 sh.21,038
NBIXGeorge Soros 2007-12-31 Sold Out -0.01%$4.4 - $13.02
($9)		 $ 11.7531%Sold Out0
NBIXGeorge Soros 2007-09-30 Add$9.69 - $11.88
($10.6)		 $ 11.7511%Add 61.87%20,362
NBIXGeorge Soros 2007-06-30 Buy $11.39 - $14.14
($12.4)		 $ 11.75-5%New holding, 12579 sh.12,579
NBIXGeorge Soros 2006-12-31 Sold Out -0.02%$7.72 - $12.55
($10.2)		 $ 11.7515%Sold Out0
NBIXGeorge Soros 2006-09-30 Buy 0.02%$8.91 - $10.93
($10.1)		 $ 11.7516%New holding, 35000 sh.35,000
NBIXGeorge Soros 2006-03-31 Buy 0.23%$59.43 - $70.41
($64.8)		 $ 11.75-82%New holding, 100000 sh.100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 18

NBIX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


NBIX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BVF PARTNERS L P/IL10% Owner 2011-10-12Buy29,500$5.9697.15view
BVF PARTNERS L P/IL10% Owner 2011-10-11Buy73,900$5.6109.82view
OBrien Christopher FlintSr. VP & Chief Medical Officer 2011-02-28Sell12,320$6.8372.04view
Grigoriadis Dimitri E.Vice President, Research 2011-02-28Sell12,320$6.8272.29view
Bozigian Haig P.Sr Vice President, Development 2011-02-28Sell12,320$6.8372.04view
GORMAN KEVIN CHARLESPresident and CEO 2011-02-28Sell15,400$6.8372.04view
Coughlin Timothy PVP and CFO 2011-02-28Sell12,320$6.8372.04view
VALEUR JENSEN MARGARET EEVP and General Counsel 2011-02-28Sell12,320$6.8372.04view
BVF PARTNERS L P/IL10% Owner 2010-04-12Sell198,000$2.78322.66view
BVF PARTNERS L P/IL10% Owner 2010-03-31Sell105,000$2.7335.19view

Press Releases about NBIX:

Quarterly/Annual Reports about NBIX:

News about NBIX:

Articles On GuruFocus.com
5 Strong Healthcare Stocks For 2012 Mar 24 2012 
Consider These 5 Healthcare Stocks Now Mar 21 2012 
Neurocrine Biosciences Inc. (NBIX) VP and CFO Timothy P Coughlin sells 12,320 Shares Mar 02 2011 
Neurocrine Biosciences Inc. (NBIX) President and CEO Kevin Charles Gorman sells 15,400 Shares Mar 02 2011 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Oct 29 2010 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Jul 29 2010 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Apr 29 2010 
Neurocrine Biosciences Inc. (NBIX) VP and CFO Timothy P Coughlin sells 12,650 Shares Mar 03 2010 
Neurocrine Biosciences Inc. (NBIX) President and CEO Kevin Charles Gorman sells 15,609 Shares Mar 03 2010 
Neurocrine Biosciences Inc. (NBIX) President and CEO Kevin Charles Gorman sells 9,445 Shares Jan 13 2010 

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial